News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Promosome LLC Announces Successful Closing of $9.6 Million Series B Financing Round



10/27/2008 10:07:40 PM

NEW YORK, Oct. 27, 2008 (GLOBE NEWSWIRE) -- Promosome LLC, a biotechnology company specializing in innovative technologies related to the regulation of protein synthesis, today announced the successful completion of its Series B Funding Round. Initially seeking $7.5 million, Promosome has been successful in over-subscribing the round to a close of $9.6 million. These funds will be utilized to support the current commercialization efforts for its Translation Enhancing Elements (TEEs) technology as well as advancing other late stage development technologies.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES